Trial description:
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) plus Carboplatin-Paclitaxel versus Placebo plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer
Contact name:
Dr Joo Ern Ang
Trial start date:
Thursday, November 26, 2020
Trial end date:
Thursday, May 18, 2023
Trial tumour type:
Gynaecological
Show on Radiotherapy:
No
